isoxazoles has been researched along with oligonucleotides in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, BH; Kim, SJ; Lee, JY | 1 |
| Wallace, D | 1 |
| Furie, R; Toder, K; Zapantis, E | 1 |
| Guzhova, I; Margulis, B; Mikhaylova, E; Multhoff, G; Shevtsov, M; Shibata, A | 1 |
3 review(s) available for isoxazoles and oligonucleotides
| Article | Year |
|---|---|
Current and emerging lupus treatments.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Dehydroepiandrosterone; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Mycophenolic Acid; Oligonucleotides | 2001 |
Lessons Learned From the Clinical Trials of Novel Biologics and Small Molecules in Lupus Nephritis.
Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Products; Boron Compounds; Bortezomib; Clinical Trials as Topic; Drug Discovery; Glycine; Humans; Immunologic Factors; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Off-Label Use; Oligonucleotides; Quinolones; Recombinant Fusion Proteins; Rituximab; Tacrolimus; Treatment Outcome | 2015 |
Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Molecular Chaperones; Neoplasms; Oligonucleotides; Resorcinols | 2019 |
1 other study(ies) available for isoxazoles and oligonucleotides
| Article | Year |
|---|---|
Design and synthesis of isoxazole and isoxazoline linkage for replacement of nucleotide phosphodiester.
Topics: Drug Design; Isoxazoles; Oligonucleotides; Thymidine | 1998 |